Plasma rich in growth factors eye drops to treat secondary ocular surface disorders in patients with glaucoma

References

• PascoliniDMariottiSPGlobal estimates of visual impairment: 2010Br J Ophthalmol201296561461822133988
   PubMed Web of Science ®Google Scholar
• AntonAAndradaMTMujicaVCalleMAPortelaJMayoAPrevalence of primary open-angle glaucoma in a Spanish population: the Segovia studyJ Glaucoma200413537137615354074
   PubMed Web of Science ®Google Scholar
• ChiselitaDNon-penetrating deep sclerectomy versus trabeculectomy in primary open-angle glaucoma surgeryEye (Lond)200115Pt 219720111339590
   PubMed Web of Science ®Google Scholar
• MermoudASchnyderCCNonpenetrating filtering surgery in glaucomaCurr Opin Ophthalmol200011215115710848223
   PubMedGoogle Scholar
• LachkarYHamardPNonpenetrating filtering surgeryCurr Opin Ophthalmol200213211011511880725
   PubMedGoogle Scholar
• LachkarYNeverauskieneJJeanteur-LunelMNNonpenetrating deep sclerectomy: a 6-year retrospective studyEur J Ophthalmol2004141263615005582
   PubMed Web of Science ®Google Scholar
• BaudouinCLabbeALiangHPaulyABrignole-BaudouinFPreservatives in eyedrops: the good, the bad and the uglyProg Retin Eye Res201029431233420302969
   PubMed Web of Science ®Google Scholar
• MichaelALChristopheBJulesBThe definition and classification of dry eye disease: report of the definition and classification subcommittee of the International Dry Eye WorkShop (2007)Ocul Surf200752759217508116
   PubMed Web of Science ®Google Scholar
• MonacoGCacioppoVConsonniDTroianoPEffects of osmoprotection on symptoms, ocular surface damage, and tear film modifications caused by glaucoma therapyEur J Ophthalmol2011213724325020872359
   PubMed Web of Science ®Google Scholar
• AlioJLColechaJRPastorSRodriguezAArtolaASymptomatic dry eye treatment with autologous platelet-rich plasmaOphthalmic Res200739312412917374962
   PubMed Web of Science ®Google Scholar
• AlioJLRodriguezAEMartinezLMRioALAutologous fibrin membrane combined with solid platelet-rich plasma in the management of perforated corneal ulcers: a pilot studyJAMA Ophthalmol2013131674575123559361
   PubMed Web of Science ®Google Scholar
• AnituaEPradoROriveGClosing regulatory gaps : new ground rules for platelet-rich plasmaTrends Biotechnol201533949249526319248
   PubMed Web of Science ®Google Scholar
• FreireVAndolloNEtxebarriaJDuranJAMoralesMCIn vitro   effects of three blood derivatives on human corneal epithelial cellsInvest Ophthalmol Vis Sci20125395571557822786903
   PubMed Web of Science ®Google Scholar
• FreireVAndolloNEtxebarriaJHernaez-MoyaRDuranJAMoralesMCCorneal wound healing promoted by 3 blood derivatives: an in vitro and in vivo comparative studyCornea201433661462024727633
   PubMed Web of Science ®Google Scholar
• RiestraACAlonso-HerrerosJMMerayo-LlovesJPlasma rico en plaquetas en superficie ocularArch Soc Esp Oftalmol20169110475490 Spanish27062018
   PubMedGoogle Scholar
• AnituaEMuruzabalFTayebbaAAutologous serum and plasma rich in growth factors in ophthalmology: preclinical and clinical studiesActa Ophthalmol2015938e605e61425832910
   PubMed Web of Science ®Google Scholar
• AnituaEMuruzabalFde la FuenteMMerayoJDuranJOriveGPlasma rich in growth factors for the treatment of ocular surface diseasesCurr Eye Res201641787588226828610
   PubMed Web of Science ®Google Scholar
• Merayo-LlovesJSanchez-AvilaRMRiestraACSafety and efficacy of autologous plasma rich in growth factors eye drops for the treatment of evaporative dry eyeOphthalmic Res2016562687327229893
   PubMed Web of Science ®Google Scholar
• Merayo-LlovesJSanchezRMRiestraACAutologous plasma rich in growth factors eyedrops in refractory cases of ocular surface disordersOphthalmic Res2015552536126569104
   PubMed Web of Science ®Google Scholar
• AnituaEAlonsoRGirbauCAguirreJJMuruzabalFOriveGAntibacterial effect of plasma rich in growth factors (PRGF®-Endoret®) against Staphylococcus aureus and Staphylococcus epidermidis strainsClin Exp Dermatol201237665265722329713
   PubMed Web of Science ®Google Scholar
• SchiffmanRMChristiansonMDJacobsenGHirschJDReisBLReliability and validity of the Ocular Surface Disease IndexArch Ophthalmol2000118561562110815152
   PubMedGoogle Scholar
• OnizukaNUematsuMKusanoMSasakiHSuzumaKKitaokaTInfluence of different additives and their concentrations on corneal toxicity and antimicrobial effect of benzalkonium chlorideCornea201433552152624619166
   PubMed Web of Science ®Google Scholar
• BaudouinCPisellaPJFillacierKOcular surface inflammatory changes induced by topical antiglaucoma drugs: human and animal studiesOphthalmology1999106355656310080214
   PubMed Web of Science ®Google Scholar
• PisellaPJPouliquenPBaudouinCPrevalence of ocular symptoms and signs with preserved and preservative free glaucoma medicationBr J Ophthalmol200286441842311914211
   PubMed Web of Science ®Google Scholar
• FreireVAndolloNEtxebarriaJDuránJAMoralesMCIn vitro effects of three blood derivatives on human corneal epithelial cellsInvest Ophthalmol Vis Sci20125395571557822786903
   PubMed Web of Science ®Google Scholar
• FreireVAndolloNEtxebarriaJHernáez-MoyaRDuránJAMoralesMCCorneal wound healing promoted by 3 blood derivatives: an in vitro and in vivo comparative studyCornea201433661462024727633
   PubMed Web of Science ®Google Scholar
• AnituaEMuruzabalFAlcaldeIMerayo-LlovesJOriveGPlasma rich in growth factors (PRGF-Endoret) stimulates corneal wound healing and reduces haze formation after PRK surgeryExp Eye Res201311515316123872360
   PubMed Web of Science ®Google Scholar
• Lopez-PlandolitSMoralesMCFreireVEtxebarriaJDuranJAPlasma rich in growth factors as a therapeutic agent for persistent corneal epithelial defectsCornea201029884384820508516
   PubMed Web of Science ®Google Scholar
• Lopez-PlandolitSMoralesMCFreireVGrauAEDuranJAEfficacy of plasma rich in growth factors for the treatment of dry eyeCornea201130121312131722012030
   PubMed Web of Science ®Google Scholar
• AlioJLPastorSRuiz-ColechaJRodriguezAArtolaATreatment of ocular surface syndrome after LASIK with autologous platelet-rich plasmaJ Refract Surg200723661761917598582
   PubMed Web of Science ®Google Scholar
• Sanchez-AvilaRMMerayo-LlovesJRiestraACTreatment of patients with neurotrophic keratitis stages 2 and 3 with plasma rich in growth factors (PRGF-Endoret) eye-dropsInt Ophthalmol Epub2017615
   Web of Science ®Google Scholar
• AgarwalRAgarwalPFuture target molecules in antiglaucoma therapy: tgf-Beta may have a role to playOphthalmic Res201043111019829006
   PubMed Web of Science ®Google Scholar
• WangJHarrisAPrendesMATargeting transforming growth factor-beta signaling in primary open-angle glaucomaJ Glaucoma201726439039528169917
   PubMed Web of Science ®Google Scholar